Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig B Langman

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Pediatric Nephrology (Berlin, Germany)|December 8, 2017
Contribution of symmetric dimethylarginine to GFR decline in pediatric chronic kidney diseaseEllen R Brooks, Shannon Haymond, Alfred Rademaker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2007
Renal function and bisphosphonate safetySusan M Ott, Tilman Drueke, Grahame Elder, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2005
The state of pediatric bone: summary of the ASBMR pediatric bone initiativeGordon L Klein, Lorraine A Fitzpatrick, Craig B Langman, et al.
American Journal of Nephrology|May 11, 2016
Assessment of Urine Proteomics in Type 1 Primary HyperoxaluriaEllen R Brooks, Bernd Hoppe, Dawn S Milliner, et al.
Clinical Biochemistry|June 7, 2016
Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementationYuguan Liu, Lawrence S Weisberg, Craig B Langman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 9, 2020
Pathophysiology and Treatment of Enteric HyperoxaluriaCeleste Witting, Craig B Langman, Dean Assimos, et al.
The Journal of Nutrition|January 7, 2003
Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoosSusan D Crissey, Kimberly D Ange, Krista L Jacobsen, et al.
American Journal of Nephrology|August 14, 2008
Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluriaDanica Grujic, Eduardo C Salido, Bhami C Shenoy, et al.
JAMA Network Open|April 14, 2023
Adherence to the 2017 Clinical Practice Guidelines for Pediatric Hypertension in Safety-Net ClinicsAllison J Carroll, Yacob G Tedla, Roxane Padilla, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safetyCraig B Langman, Larry A Greenbaum, Minnie Sarwal, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Pediatric Nephrology (Berlin, Germany)|December 8, 2017
Contribution of symmetric dimethylarginine to GFR decline in pediatric chronic kidney diseaseEllen R Brooks, Shannon Haymond, Alfred Rademaker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2007
Renal function and bisphosphonate safetySusan M Ott, Tilman Drueke, Grahame Elder, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2005
The state of pediatric bone: summary of the ASBMR pediatric bone initiativeGordon L Klein, Lorraine A Fitzpatrick, Craig B Langman, et al.
American Journal of Nephrology|May 11, 2016
Assessment of Urine Proteomics in Type 1 Primary HyperoxaluriaEllen R Brooks, Bernd Hoppe, Dawn S Milliner, et al.
Clinical Biochemistry|June 7, 2016
Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementationYuguan Liu, Lawrence S Weisberg, Craig B Langman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 9, 2020
Pathophysiology and Treatment of Enteric HyperoxaluriaCeleste Witting, Craig B Langman, Dean Assimos, et al.
The Journal of Nutrition|January 7, 2003
Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoosSusan D Crissey, Kimberly D Ange, Krista L Jacobsen, et al.
American Journal of Nephrology|August 14, 2008
Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluriaDanica Grujic, Eduardo C Salido, Bhami C Shenoy, et al.
JAMA Network Open|April 14, 2023
Adherence to the 2017 Clinical Practice Guidelines for Pediatric Hypertension in Safety-Net ClinicsAllison J Carroll, Yacob G Tedla, Roxane Padilla, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safetyCraig B Langman, Larry A Greenbaum, Minnie Sarwal, et al.
Pageof 12